- Home
- PROK vs FMAO Comparison
PROK vs FMAO Comparison
Compare PROK & FMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- FMAO
- Stock Information
- Founded
- PROK 2015
- FMAO 1897
- Country
- PROK United States
- FMAO United States
- Employees
- PROK N/A
- FMAO N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- FMAO Savings Institutions
- Sector
- PROK Health Care
- FMAO Finance
- Exchange
- PROK Nasdaq
- FMAO Nasdaq
- Market Cap
- PROK 384.2M
- FMAO 356.9M
- IPO Year
- PROK N/A
- FMAO N/A
- Fundamental
- Price
- PROK $2.35
- FMAO $25.14
- Analyst Decision
- PROK Buy
- FMAO
- Analyst Count
- PROK 5
- FMAO 0
- Target Price
- PROK $6.25
- FMAO N/A
- AVG Volume (30 Days)
- PROK 3.3M
- FMAO 19.7K
- Earning Date
- PROK 08-12-2025
- FMAO 07-28-2025
- Dividend Yield
- PROK N/A
- FMAO 3.40%
- EPS Growth
- PROK N/A
- FMAO 38.39
- EPS
- PROK N/A
- FMAO 2.16
- Revenue
- PROK $527,000.00
- FMAO $108,632,000.00
- Revenue This Year
- PROK $105.79
- FMAO N/A
- Revenue Next Year
- PROK N/A
- FMAO $6.16
- P/E Ratio
- PROK N/A
- FMAO $12.07
- Revenue Growth
- PROK N/A
- FMAO 13.86
- 52 Week Low
- PROK $0.46
- FMAO $20.88
- 52 Week High
- PROK $7.13
- FMAO $34.15
- Technical
- Relative Strength Index (RSI)
- PROK 43.77
- FMAO 56.91
- Support Level
- PROK $2.16
- FMAO $23.35
- Resistance Level
- PROK $2.46
- FMAO $26.11
- Average True Range (ATR)
- PROK 0.34
- FMAO 1.01
- MACD
- PROK -0.16
- FMAO 0.07
- Stochastic Oscillator
- PROK 7.14
- FMAO 72.69
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About FMAO Farmers & Merchants Bancorp Inc.
Farmers & Merchants Bancorp Inc is a holding company based in Ohio. The company is engaged in general commercial banking business. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.